Rofecoxib



Indications and Reactions:

Role Indications Reactions
Primary
Costochondritis 33.3%
Joint Dislocation 33.3%
Pain 33.3%
Dislocation Of Vertebra 50.0%
Pancreatic Disorder 50.0%
Secondary
Product Used For Unknown Indication 26.8%
Drug Use For Unknown Indication 18.6%
Headache 15.4%
Bone Disorder 7.7%
Respiratory Disorder 7.7%
Hypertension 2.8%
Pain 2.5%
Arthralgia 2.4%
Drug Therapy 2.1%
Rheumatoid Arthritis 1.9%
Arthritis 1.8%
Osteoarthritis 1.6%
Muscle Spasms 1.5%
Nutritional Support 1.5%
Diabetes Mellitus 1.3%
Ankylosing Spondylitis 0.9%
Infection 0.9%
Cardiac Failure 0.8%
Intraoperative Care 0.8%
Ill-defined Disorder 0.7%
Drug Hypersensitivity 12.0%
Vestibular Disorder 10.7%
Haematoma 6.7%
Syncope 6.7%
Vomiting 6.7%
Atrial Fibrillation 5.3%
Lactic Acidosis 5.3%
Status Asthmaticus 5.3%
Tachycardia 5.3%
Malaise 4.0%
Renal Injury 4.0%
Somnolence 4.0%
Thrombocytopenia 4.0%
Treatment Noncompliance 4.0%
Acquired Haemophilia 2.7%
Colitis Collagenous 2.7%
Dislocation Of Vertebra 2.7%
Enterovesical Fistula 2.7%
Gastrointestinal Haemorrhage 2.7%
Haemorrhage 2.7%
Concomitant
Drug Use For Unknown Indication 51.1%
Rheumatoid Arthritis 20.3%
Product Used For Unknown Indication 3.6%
Back Pain 3.3%
Hypertension 2.4%
Depression 2.0%
Diabetes Mellitus 1.7%
Bipolar Disorder 1.4%
Crohn's Disease 1.4%
Ill-defined Disorder 1.4%
Sciatica 1.4%
Nuclear Magnetic Resonance Imaging 1.3%
Allergy Test 1.2%
Hypersensitivity 1.2%
Osteoporosis 1.2%
Breast Cancer 1.0%
Osteoarthritis 1.0%
Arthritis 0.9%
Blood Corticotrophin Decreased 0.9%
Osteoporosis Prophylaxis 0.9%
Circulatory Collapse 7.7%
Death 7.7%
Renal Failure Acute 7.7%
Vomiting 7.7%
Myocardial Infarction 6.7%
Rheumatoid Arthritis 6.7%
Urinary Tract Infection 6.7%
Serotonin Syndrome 4.8%
Tachycardia 4.8%
Weight Decreased 4.8%
Joint Dislocation 3.8%
Joint Swelling 3.8%
Neck Pain 3.8%
Pain 3.8%
Pleurisy 3.8%
Type 2 Diabetes Mellitus 3.8%
Bronchial Carcinoma 2.9%
Endometrial Cancer 2.9%
Hypotension 2.9%
Lower Respiratory Tract Infection 2.9%
Interacting
Drug Use For Unknown Indication 28.6%
Coagulopathy 14.3%
Diabetes Mellitus Non-insulin-dependent 14.3%
Osteoarthritis 14.3%
Pain 14.3%
Type 2 Diabetes Mellitus 14.3%
Prothrombin Time Prolonged 40.0%
Vomiting 40.0%
Hepatotoxicity 20.0%